Tekla Life Sciences Investors (HQL) — Working Capital to Net Assets Ratio
Tekla Life Sciences Investors (HQL) has a Working Capital to Net Assets ratio of 0.1% as of September 2025. Working capital of $531.60K (current assets of $1.25 Million minus current liabilities of $720.90K) is measured against net assets of $513.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Tekla Life Sciences Investors financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tekla Life Sciences Investors Working Capital to Net Assets (1996–2025)
This chart shows how Tekla Life Sciences Investors's Working Capital to Net Assets ratio has evolved across 25 annual periods from 1996 to 2025. As of September 2025, the ratio stands at 0.1%, reflecting working capital of $531.60K against net assets of $513.66 Million USD. See Tekla Life Sciences Investors defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Tekla Life Sciences Investors (1996–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tekla Life Sciences Investors from 1996 to 2025, covering 25 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Tekla Life Sciences Investors worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.1% | $531.60K | $513.66 Million | $1.25 Million | $720.90K | ▲ +0.2 pp |
| 2024 | -0.1% | $-607.00K | $459.69 Million | $281.61K | $888.61K | ▲ +1.0 pp |
| 2022 | -1.1% | $-4.48 Million | $397.90 Million | $623.92K | $5.10 Million | ▲ +0.9 pp |
| 2021 | -2.0% | $-10.60 Million | $523.44 Million | $144.66K | $10.75 Million | ▼ -1.9 pp |
| 2020 | -0.1% | $-507.35K | $483.57 Million | $73.90K | $581.24K | ▼ -0.7 pp |
| 2019 | 0.6% | $2.27 Million | $384.16 Million | $5.09 Million | $2.82 Million | ▼ -1.3 pp |
| 2018 | 1.9% | $8.84 Million | $475.49 Million | $11.19 Million | $2.35 Million | ▲ +2.0 pp |
| 2017 | -0.1% | $-676.96K | $466.35 Million | $633.44K | $1.31 Million | ▼ -4.4 pp |
| 2016 | 4.2% | $17.46 Million | $414.97 Million | $20.12 Million | $2.66 Million | ▲ +0.6 pp |
| 2015 | 3.6% | $16.70 Million | $462.84 Million | $21.72 Million | $5.01 Million | ▲ +2.7 pp |
| 2014 | 0.9% | $4.00 Million | $444.09 Million | $4.76 Million | $754.55K | ▼ -1.3 pp |
| 2013 | 2.2% | $6.62 Million | $302.29 Million | $7.15 Million | $530.12K | ▼ -2.0 pp |
| 2012 | 4.2% | $9.52 Million | $227.08 Million | $9.92 Million | $404.67K | ▲ +4.1 pp |
| 2011 | 0.1% | $200.00K | $170.60 Million | $800.00K | $600.00K | ▲ +1.8 pp |
| 2010 | -1.7% | $-4.30 Million | $251.40 Million | $500.00K | $4.80 Million | ▲ +1.3 pp |
| 2009 | -3.0% | $-7.50 Million | $248.60 Million | $8.50 Million | $16.00 Million | ▼ -2.7 pp |
| 2008 | -0.3% | $-900.00K | $277.80 Million | $1.80 Million | $2.70 Million | ▼ -0.2 pp |
| 2007 | -0.1% | $-400.00K | $308.00 Million | $200.00K | $600.00K | ▲ +0.1 pp |
| 2006 | -0.3% | $-700.00K | $268.10 Million | $1.40 Million | $2.10 Million | ▼ -1.1 pp |
| 2005 | 0.8% | $1.90 Million | $229.30 Million | $2.50 Million | $600.00K | ▲ +0.7 pp |
| 2004 | 0.2% | $300.00K | $191.80 Million | $1.20 Million | $900.00K | ▲ +0.7 pp |
| 2003 | -0.6% | $-1.10 Million | $190.40 Million | $1.20 Million | $2.30 Million | ▼ -1.3 pp |
| 2001 | 0.7% | $1.60 Million | $215.10 Million | $1.90 Million | $300.00K | ▲ +1.8 pp |
| 1998 | -1.1% | $-1.10 Million | $100.00 Million | $100.00K | $1.20 Million | ▼ -0.9 pp |
| 1996 | -0.2% | $-200.00K | $123.10 Million | $200.00K | $400.00K | — |